231-511-9

应用筛选条件

关键词:'231-511-9'

显示 1-10 #N/A 983 条结果关于 "231-511-9" 范围网站内容

成熟的microRNA（miRNA）是一类天然生成的小型非编码RNA分子，长约21-25个核苷酸。microRNA与一种或多种信使RNA（mRNA）分子部分互补，其主要功能是以各种方式下调基因表达，包括翻译抑制，mRNA剪切和脱腺苷化。

X-tremeGENE™ 9 DNA Transfection Reagent Protocol

Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).

CRISPR Cas 9 Nuclease RNA-guided Genome Editing

Learn about CRISPR Cas9, what it is and how it works. CRISPR is a new, affordable genome editing tool enabling access to genome editing for all.

Color Determination of sugar based on ICUMSA Color GS2-9

Learn about the ICUMSA® Method GS2-9 (2024) to measure the color of sample solutions of white sugar or highly pure sugar syrup of color index up to 600 IU.

X-tremeGENE™ 9 DNA转染试剂实验方案

约转染前24小时接种细胞，确保细胞处于最佳密度（7090 %融合度）。

Merck Expands in Gillingham, UK, Boosts Distribution Capabilities

Merck today announced the completion of a £9 million expansion to its Gillingham distribution center.

Accelerated mAb Development Program – From Transfection to GMP Drug Substance in 9 Months

The accelerated mAb development program delivers GMP drug substance nine months from transfection. We designed the mAbExpress™ program to be fast, cost effective, and appropriate for the early clinical phase of your program, with regulatory support throughout.

How to Boost AAV Titer with Feed Supplementation in both HEK293 and Sf-9 Platforms

In this webinar, you will learn wow to boost AAV titers in HEK293 and Sf-9 cell lines as well as getting some insider tips on volume and timing optimization.

ECMatrix™ Laminin Substrates are Superior Xeno-free Extracellular Matrix Coatings for Feeder-free Human Pluripotent Stem Cell Cultures

No precoat needed. Single cell iPSC passaging. Human recombinant laminin-511 E8 allows greater iPS cell adhesion and proliferation rates vs. Matrigel and laminin-521.

Analysis of 17 Cannabinoids in Hemp and Cannabis

HPLC separation of 17 important cannabinoids including CBD, delta 9 THC and THCA. Read the application note.

1/99